Episealer® publication available online
Episurf Medical (Nasdaq: EPIS B) today communicates that a publication with the title “Successful Treatment of Femoral Chondral Lesions with a Novel Customized Metal Implant at Midterm Follow-Up” from a Swedish prospective multicentre study has been published in the scientific journal Cartilage. In total, 30 Episealer® patients are included in the study and the average follow-up time is 55 months (subjective outcome scores at 24 months, survival data at 24 – 86 months, mean of 55 months). The authors conclude the study with the words “The risk of OA progression and implant loosening is